Objectives: The objective of this study is to clarify the role of (G4C2)n expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. Methods: C9orf72 (G4C2)n repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. Results: A pathogenic (G4C2)n.60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G4C2)n repeats; however, we could not detect a robust association between the C9orf72 (G4C2)n repeat and PD, and the population attributable risk was low. Conclusions: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease / Theuns, J.; Verstraeten, A.; Sleegers, K.; Wauters, E.; Gijselinck, I.; Smolders, S.; Crosiers, D.; Corsmit, E.; Elinck, E.; Sharma, M.; Kruger, R.; Lesage, S.; Brice, A.; Chung, S. J.; Kim, M. -J.; Kim, Y. J.; Ross, O. A.; Wszolek, Z. K.; Rogaeva, E.; Xi, Z.; Lang, A. E.; Klein, C.; Weissbach, A.; Mellick, G. D.; Silburn, P. A.; Hadjigeorgiou, G. M.; Dardiotis, E.; Hattori, N.; Ogaki, K.; Tan, E. -K.; Zhao, Y.; Aasly, J.; Valente, E. M.; Petrucci, S.; Annesi, G.; Quattrone, A.; Ferrarese, C.; Brighina, L.; Deutschlander, A.; Puschmann, A.; Nilsson, C.; Garraux, G.; Ledoux, M. S.; Pfeiffer, R. F.; Boczarska-Jedynak, M.; Opala, G.; Maraganore, D. M.; Engelborghs, S.; De Deyn, P. P.; Cras, P.; Cruts, M.; Van Broeckhoven, C.. - In: NEUROLOGY. - ISSN 0028-3878. - 83:21(2014), pp. 1906-1913. [10.1212/WNL.0000000000001012]

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease

Petrucci S.;
2014

Abstract

Objectives: The objective of this study is to clarify the role of (G4C2)n expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. Methods: C9orf72 (G4C2)n repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. Results: A pathogenic (G4C2)n.60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G4C2)n repeats; however, we could not detect a robust association between the C9orf72 (G4C2)n repeat and PD, and the population attributable risk was low. Conclusions: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.
2014
c9orf72 protein; cohort studies; dna repeat expansion; female; humans; internationality; male; middle aged; parkinson disease; proteins
01 Pubblicazione su rivista::01a Articolo in rivista
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease / Theuns, J.; Verstraeten, A.; Sleegers, K.; Wauters, E.; Gijselinck, I.; Smolders, S.; Crosiers, D.; Corsmit, E.; Elinck, E.; Sharma, M.; Kruger, R.; Lesage, S.; Brice, A.; Chung, S. J.; Kim, M. -J.; Kim, Y. J.; Ross, O. A.; Wszolek, Z. K.; Rogaeva, E.; Xi, Z.; Lang, A. E.; Klein, C.; Weissbach, A.; Mellick, G. D.; Silburn, P. A.; Hadjigeorgiou, G. M.; Dardiotis, E.; Hattori, N.; Ogaki, K.; Tan, E. -K.; Zhao, Y.; Aasly, J.; Valente, E. M.; Petrucci, S.; Annesi, G.; Quattrone, A.; Ferrarese, C.; Brighina, L.; Deutschlander, A.; Puschmann, A.; Nilsson, C.; Garraux, G.; Ledoux, M. S.; Pfeiffer, R. F.; Boczarska-Jedynak, M.; Opala, G.; Maraganore, D. M.; Engelborghs, S.; De Deyn, P. P.; Cras, P.; Cruts, M.; Van Broeckhoven, C.. - In: NEUROLOGY. - ISSN 0028-3878. - 83:21(2014), pp. 1906-1913. [10.1212/WNL.0000000000001012]
File allegati a questo prodotto
File Dimensione Formato  
Thenus_ Neurol-Global_2014.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 478.76 kB
Formato Adobe PDF
478.76 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1383107
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 54
social impact